277 related articles for article (PubMed ID: 29377625)
1. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.
Sokol J; Timp JF; le Cessie S; van Hylckama-Vlieg A; Rosendaal FR; Kubisz P; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625
[TBL] [Abstract][Full Text] [Related]
2. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study.
Di Minno MN; Dentali F; Lupoli R; Ageno W
Circulation; 2014 Jan; 129(4):497-503. PubMed ID: 24146249
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
[TBL] [Abstract][Full Text] [Related]
4. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
[TBL] [Abstract][Full Text] [Related]
5. External validation of the DASH prediction rule: a retrospective cohort study.
Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
[TBL] [Abstract][Full Text] [Related]
6. β-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study.
Croles FN; Mulder R; Mulder AB; Lukens MV; Meijer K
Thromb Res; 2018 Aug; 168():47-52. PubMed ID: 29902631
[TBL] [Abstract][Full Text] [Related]
7. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
[TBL] [Abstract][Full Text] [Related]
8. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
Baglin T; Luddington R; Brown K; Baglin C
Lancet; 2003 Aug; 362(9383):523-6. PubMed ID: 12932383
[TBL] [Abstract][Full Text] [Related]
9. Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode.
Farren-Dai L; Carrier M; Kovacs J; Rodger M; Kovacs MJ; Le Gal G;
J Thromb Haemost; 2017 Oct; 15(10):1977-1980. PubMed ID: 28795538
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of mannose-binding lectin and future risk of venous thromboembolism.
Liang RA; Høiland II; Ueland T; Aukrust P; Snir O; Hindberg K; Braekkan SK; Garred P; Mollnes TE; Hansen JB
J Thromb Haemost; 2019 Oct; 17(10):1661-1669. PubMed ID: 31220397
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019.
Liu Y; Cai J; Wang C; Jin J; Qu L
J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1099-1111.e6. PubMed ID: 33529719
[TBL] [Abstract][Full Text] [Related]
12. Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow-up study.
Morelli VM; Lijfering WM; Rosendaal FR; Cannegieter SC
J Thromb Haemost; 2017 Apr; 15(4):695-701. PubMed ID: 28135040
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study.
Di Minno MN; Dentali F; Veglia F; Russolillo A; Tremoli E; Ageno W
Thromb Haemost; 2013 Jan; 109(1):167-9. PubMed ID: 23196409
[No Abstract] [Full Text] [Related]
14. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.
Enga KF; Rye-Holmboe I; Hald EM; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
J Thromb Haemost; 2015 Jan; 13(1):10-6. PubMed ID: 25330989
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
Reiner MF; Stivala S; Limacher A; Bonetti NR; Méan M; Egloff M; Rodondi N; Aujesky D; von Schacky C; Lüscher TF; Camici GG; Beer JH
J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
[TBL] [Abstract][Full Text] [Related]
17. Incidence of venous thromboembolism in hospitalized patients with COVID-19.
Middeldorp S; Coppens M; van Haaps TF; Foppen M; Vlaar AP; Müller MCA; Bouman CCS; Beenen LFM; Kootte RS; Heijmans J; Smits LP; Bonta PI; van Es N
J Thromb Haemost; 2020 Aug; 18(8):1995-2002. PubMed ID: 32369666
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.
Rézig S; Mao RL; Couturaud F; Lacut K; Delluc A
Thromb Haemost; 2019 Mar; 119(3):490-495. PubMed ID: 30685873
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
20. Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
Di Nisio M; van Es N; Carrier M; Wang TF; Garcia D; Segers A; Weitz J; Buller H; Raskob G
J Thromb Haemost; 2019 Nov; 17(11):1866-1874. PubMed ID: 31271705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
